GLP-1 Drugs May Ease Psoriasis in Some Patients, Study Finds
A new study finds GLP-1 receptor agonists improved psoriasis in some patients, reinforcing the link between metabolic health and skin inflammation.
Topic
Topic
A new study finds GLP-1 receptor agonists improved psoriasis in some patients, reinforcing the link between metabolic health and skin inflammation.
A new study links GLP-1 receptor agonists to onycholysis — nail-plate detachment — and a broader cluster of nail disorders, addin…
An EADV 2026 survey of 1,904 patients found 39% of GLP-1 users reported nail detachment versus 9% of nonusers, with gaps persisti…
Researchers have launched a genetic study testing whether GLP-1 receptor agonists share biological pathways with androgenetic alo…
Medscape reports quality-of-life gains when a GLP-1 receptor agonist is added to biologic therapy in psoriatic disease, sharpenin…